Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax (Q36870766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Bacillus anthracis

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

H S Heine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

J Bassett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

L Miller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A Bassett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

B E Ivins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

D Lehoux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

F F Arhin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

T R Parr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

7 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

3350-3357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens.

10 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Murine aerosol challenge model of anthrax

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Penicillinase adaptation in B. cereus; adaptive enzyme formation in the absence of free substrate.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Mechanism of action of oritavancin and related glycopeptide antibiotics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Anthrax as a biological weapon, 2002: updated recommendations for management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Anthrax as a potential biological warfare agent

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

The Biological Weapons Program of the Former Soviet Union

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533456

Antimicrobial susceptibility of Bacillus anthracis

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18606841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Postexposure prophylaxis against experimental inhalation anthrax

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18606841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anthrax; a report of one hundred seventeen cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18606841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00360-08

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

18606841

1 reference